Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 158,687 | 145,493 | 128,853 | 181,468 | 34,597 |
| Depreciation Amortization | 24,461 | 22,551 | 23,918 | 24,616 | 21,078 |
| Income taxes - deferred | -7,301 | -29,298 | -13,419 | -85,943 | N/A |
| Accounts receivable | -13,754 | -8,893 | -19,400 | -19,897 | -12,667 |
| Accounts payable and accrued liabilities | 3,949 | -5,384 | 8,949 | 2,785 | -1,555 |
| Other Working Capital | 91,817 | -7,321 | 35,035 | -4,106 | 631 |
| Other Operating Activity | 90,340 | 102,673 | 55,451 | 45,543 | 56,473 |
| Operating Cash Flow | $348,199 | $219,821 | $219,387 | $144,466 | $98,557 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -310 | -1,153 | -312 | -172 | -298 |
| Net Acquisitions | N/A | -33,069 | -36,967 | N/A | N/A |
| Purchase Of Investment | -86,151 | -105,289 | -127,469 | -110,729 | N/A |
| Sale Of Investment | 81,062 | 98,527 | 118,309 | 9,069 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -100,000 |
| Other Investing Activity | -34,250 | -26,500 | 0 | -40,000 | -100,000 |
| Investing Cash Flow | $-39,649 | $-67,484 | $-46,439 | $-141,832 | $-100,298 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 200,000 | N/A | 200,000 |
| Debt Repayment | -16,250 | -15,000 | -201,250 | -2,000 | -200,500 |
| Common Stock Issued | 10,205 | 6,501 | 5,055 | 8,841 | 39,371 |
| Common Stock Repurchased | 0 | 0 | -100,000 | N/A | N/A |
| Other Financing Activity | -3,004 | -2,497 | -9,357 | 0 | -31,452 |
| Financing Cash Flow | $-9,049 | $-10,996 | $-105,552 | $6,841 | $7,419 |
| Beginning Cash Position | 453,271 | 311,930 | 244,534 | 235,059 | 229,381 |
| End Cash Position | 752,772 | 453,271 | 311,930 | 244,534 | 235,059 |
| Net Cash Flow | $299,501 | $141,341 | $67,396 | $9,475 | $5,678 |
| Free Cash Flow | |||||
| Operating Cash Flow | 348,199 | 219,821 | 219,387 | 144,466 | 98,557 |
| Capital Expenditure | -310 | -1,153 | -312 | -172 | -298 |
| Free Cash Flow | 347,889 | 218,668 | 219,075 | 144,294 | 98,259 |